EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Herpes zoster reactivation temporally associated with recombinant zoster vaccination in a patient with IPAF and progressive pulmonary fibrosis: a case report

Firdevs Ulutaş, Süleyman Akgöl, Veli Çobankara

Romanian Journal of Rheumatology · 30.06.2026 · 35 (2) · 121

DOI: 10.37897/rjr.2026.2.7 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Romanian Journal of Rheumatology, online erschienen am 29.06.2026. Verfasst von Firdevs Ulutaş und 2 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recombinant zoster vaccine (RZV, Shingrix) is recommended for older adults and immunocompromised individuals because of its high efficacy in preventing herpes zoster and related complications. Although RZV does not contain live virus and has a favorable safety profile, rare cases of herpes zoster reactivation temporally associated with vaccination have been reported. Case presentation. A 76-year-old man with interstitial pneumonia with autoimmune features (IPAF), progressive pulmonary fibrosis (PPF), coronary artery disease, diabetes mellitus, hyperlipidemia, and heart failure was evaluated before planned rituximab therapy. As part of pre-treatment vaccination optimization, he received pneumococcal and recombinant zoster vaccines. Six days after vaccination, he developed pruritic vesicular and crusted skin lesions involving the left upper extremity and interscapular region. The lesions corresponded approximately to the C8–T1 and upper thoracic dermatomes. Herpes zoster was diagnosed clinically and treated with oral valacyclovir and topical therapy, resulting in satisfactory clinical recovery.

Conclusion

This case highlights a temporal association between RZV administration and herpes zoster reactivation in an elderly patient with multiple risk factors for viral reactivation. Causality cannot be established from a single observation, but reporting such uncommon events may contribute to post-marketing pharmacovigilance.

Zitieren

APA

Ulutaş, F., Akgöl, S., & Çobankara, V. (2026). Herpes zoster reactivation temporally associated with recombinant zoster vaccination in a patient with IPAF and progressive pulmonary fibrosis: a case report. Romanian Journal of Rheumatology, 35(2), 121. https://doi.org/10.37897/rjr.2026.2.7

Vancouver

Ulutaş F, Akgöl S, Çobankara V. Herpes zoster reactivation temporally associated with recombinant zoster vaccination in a patient with IPAF and progressive pulmonary fibrosis: a case report. Romanian Journal of Rheumatology. 2026;35(2):121. doi:10.37897/rjr.2026.2.7

BibTeX
@article{Uluta2026,
  author = {Ulutaş, Firdevs and Akgöl, Süleyman and Çobankara, Veli},
  title = {Herpes zoster reactivation temporally associated with recombinant zoster vaccination in a patient with IPAF and progressive pulmonary fibrosis: a case report},
  journal = {Romanian Journal of Rheumatology},
  year = {2026},
  volume = {35},
  number = {2},
  pages = {121},
  doi = {10.37897/rjr.2026.2.7}
}
Kostenlos starten →